Details of the Drug

General Information of Drug (ID: DMQWEJ5)

Drug Name

ImmunoVEX-timelan

Indication

Disease Entry	ICD 11	Status	REF
Melanoma	2C30	Phase 1/2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	Amgen to Acquire BioVex, a Privately Held Biotechnology Company Headquartered in Woburn, Mass